This suggests that they could have a notable impact on the treatment of MDS, but also extends to a broader spectrum of clinical implications in other cancer types associated with the SF3B1 K700E mutation, underscoring the significance and widespread applicability of our findings. Here, SF3B1 is linked to cancer.